Contract for technology transfer of regulatory T cells as a therapeutic cell therapycomposition or preventing degenerative brain diseases (Kyunghee university)
02
Contract for technology transfer of prevention or therapeutic vaccine composition about Alzheimer's disease or dementia (Kyunghee university)
02
Change from GOODMEDI to GMP BIO
01
Contract for technology transfer of composition for alopecia prevention and promotion (Ewha Woman University)
01
GMP took over GOODMEDI (Acquiring a 50% stake)
2016
연혁 상세목록
10
VT012(PM012) Development of Chinese Medicine prescription to inhibition Alzheimer's disease (Molecular Neurobiology)
00
Change from PURI MED to GOODMEDI
2015
연혁 상세목록
08
Lycii fructus Extraction base Material, Demonstrates Effectiveness on Dementia Symptoms and Memory Improvement
2014
연혁 상세목록
09
End of anti-dementia drug VT012(PM012) clinical 2 phase (Korea's Ministry of Food and Drug Safety (MFDS))
2013
연혁 상세목록
02
Approval of COPD VT014 clinical 2 phase (Korea's Ministry of Food and Drug Safety (MFDS))
2012
연혁 상세목록
10
Prove effectiveness about Bee venom, Parkinson's disease
05
Approval of anti-dementia drugs VT012(PM012) clinical 2 phase (Korea's Ministry of Food and Drug Safety (MFDS))
2011
연혁 상세목록
12
Proof of the curative effect of Bee venom and lupus glomerulonephritis of Scarcity incurable immune disease (American Journal of nephrology)
